Federal Register / Vol. 77, No. 48 / Monday, March 12, 2012 / Notices 14527 

provides guidance and assistance to 

programs on the various aspects of the 

contracts to meet their requirements. 

Remove all CAJD standard 

administrative codes for the Information 

Technology Services Office (CAJD), and 

replace with the following: 

Information Technology Services 

Office (CAJRB), Office of the Director 

(CAJRB1), Operations Branch (CARBB), 

Network Technology Branch (CAJRBC), 

Customer Services Branch (CAJRBD). 

Remove all CAJG standard 

administrative codes for the 

Management Analysis and Services 

Office (CAJG), and replace with the 

following: 

Management Analysis and Services 

Office (CAJRC), Office of the Director 

(CAJRC1), Management Assessment 

Branch (CAJRCB), Information Services 

Branch (CAJRCC), Business Process 

Analysis Branch (CAJRCD), Federal 

Advisory Committee Management 

Branch (CAJRCE), 

Remove the CAJN standard 

administrative code for the Management 

Information Systems Office (CAJN), and 

replace with Management Information 

Systems Office (CAJRD). 

After the functional statement for the 

Management Information Systems 

Office (CAJRD), insert the following: 

Office of the Chief Information 

Security Officer (CAJRE). The mission of 

the Office of the Chief Information 

Security Officer (OCISO) is to 

administer CDC’s information security 

program to protect CDC’s information, 

information systems, and information 

technology commensurate with the risk 

and magnitude of harm resulting from 

the unauthorized access, use, 

disclosure, disruption, modification, or 

destruction of information collected or 

maintained by or on behalf of the 

agency. 

Office of the Director (CAJRE1). (1) 

Manages and directs the activities and 

functions of the Office of the Chief 

Information Security Officer; (2) 

develops and maintains a CDC-wide 

information security program; (3) 

develops and maintains information 

security policies, procedures and 

control techniques to address the 

responsibilities assigned to the CDC 

under the Federal Information Security 

Management Act of 2002 (FISMA) and 

other governing statutes, regulations, 

and policies; (4) coordinates the 

professional development and operating 

procedures of CDC staff substantially 

involved in information security 

responsibilities; (5) assists CDC senior 

management concerning their FISMA 

responsibilities; and (6) ensures privacy 

management so personally identifiable 

information is appropriately collected, 

processed, stored and protected. 

Operations, Analysis and Response 

Branch (CAJREB). (1) Performs 

continuous monitoring functions 

including enterprise security log 

correlation, vulnerability and 

compliance scanning and risk 

assessments; (2) performs network 

monitoring, security event correlation, 

forensic investigations, data recovery 

and malware analysis; (3) develops and 

maintains the CDC Computer Security 

Incident Response Team; (4) performs 

cyber security incident reporting 

according to US–CERT reporting 

guidelines; (5) facilitates cyber security 

incident remediation; (6) coordinates 

with law enforcement agencies and 

participates in cyber security 

intelligence activities; (7) develops 

enterprise security architecture, firewall 

management, cyber security tool 

management and CDC information 

resource governance—security 

component; and (8) supports OCISO IT 

operations; and (9) performs security 

product research and development, 

evaluation and testing. 

Policy and Planning Branch 

(CAJREC). (1) Coordinates compliance 

and audit reviews; (2) develops cyber 

security policies and standards; (3) 

conducts system security tests and 

evaluations and identifies, assesses, 

prioritizes, and monitors the progress of 

corrective efforts for security 

weaknesses found in programs and 

systems; (4) maintains the Security 

Awareness Training program and 

coordinates significant security 

responsibilities and IT security training; 

(5) reviews and approves security and 

privacy related elements of OMB 

business cases; (6) conducts OCISO 

internal audit program and contract 

language reviews for information 

security and privacy act clearance 

decisions; (7) coordinates critical 

infrastructure protection continuity 

operations plans, data call management, 

E-Authentication and security 

requirements of CDC information 

system development; (8) conducts 

security reviews of non-standard 

software for use at CDC; and (9) 

coordinates FISMA security milestone 

oversight reporting and is the Office of 

Inspector General and Government 

Accounting Office Audit Liaison. 

Dated: March 5, 2012. 

Thomas R. Frieden, 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–5862 Filed 3–9–12; 8:45 am] 

BILLING CODE 4160–18–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Comment Request 

Proposed Projects 

Title: Performance Measures for 

Community-Centered Healthy Marriage, 

Pathways to Responsible Fatherhood 

and Community-Centered Responsible 

Fatherhood Ex-Prisoner Reentry grant 

programs. 

OMB No.: 0970–0365. 

Description: The Office of Family 

Assistance (OFA), Administration for 

Children and Families (ACF), U.S. 

Department of Health and Human 

Services (HHS), intends to request 

approval from the Office of Management 

and Budget (OMB) to renew OMB Form 

0970–0365 for the collection of 

performance measures from grantees for 

the Community-Centered Healthy 

Marriage, Pathways to Responsible 

Fatherhood and Community-Centered 

Responsible Fatherhood Ex-Prisoner 

Reentry discretionary grant programs. 

The performance measure data obtained 

from the grantees will be used by OFA 

to report on the overall performance of 

these grant programs. 

Data will be collected from all 61 

Community-Centered Healthy Marriage, 

53 Pathways to Responsible Fatherhood 

and 4 Community-Centered Responsible 

Fatherhood Ex-Prisoner Reentry 

grantees in the OFA programs. Grantees 

will report on program and participant 

outcomes in such areas as participants’ 

improvement in knowledge skills, 

attitudes, and behaviors related to 

healthy marriage and responsible 

fatherhood. Grantees will be asked to 

input data for selected outcomes for 

activities funded under the grants. 

Grantees will extract data from program 

records and will report the data twice 

yearly through an on-line data 

collection tool. Training and assistance 

will be provided to grantees to support 

this data collection process. 

Respondents: Office of Family 

Assistance Funded CommunityCentered Healthy Marriage, Pathways to 

Responsible Fatherhood and 

Community-Centered Responsible 

Fatherhood Ex-Prisoner Reentry 

Grantees. 


pmangrum on DSK3VPTVN1PROD with NOTICES
14528 Federal Register / Vol. 77, No. 48 / Monday, March 12, 2012 / Notices 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per 

response 

Total annual 

burden hours 

Performance measure reporting form (for private sector affected public) ...... 103 2 0.8 165 

Performance measure reporting form (for State, local, and tribal government 

affected public) ............................................................................................. 15 2 0.8 30 

Estimated Total Annual Burden Hours ..................................................... ........................ ........................ ........................ 195 

In compliance with the requirements 

of Section 506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

comments may be forwarded by writing 

to the Administration for Children and 

Families, Office of Planning, Research 

and Evaluation, 370 L’Enfant 

Promenade SW., Washington, DC 20447, 

Attn: ACF Reports Clearance Officer. 

Email address: 

infocollection@acf.hhs.gov. All requests 

should be identified by the title of the 

information collection. 

The Department specifically requests 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; 

(c) the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 2012–5835 Filed 3–9–12; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2012–N–0001] 

Preparation for International 

Conference on Harmonization Steering 

Committee and Expert Working Group 

Meetings in Fukuoka, Japan; Regional 

Public Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public meeting. 

The Food and Drug Administration 

(FDA) is announcing a public meeting 

entitled ‘‘Preparation for ICH Steering 

Committee and Expert Working Group 

Meetings in Fukuoka, Japan’’ to provide 

information and receive comments on 

the International Conference on 

Harmonization (ICH) as well as the 

upcoming meetings in Fukuoka, Japan. 

The topics to be discussed are the topics 

for discussion at the forthcoming ICH 

Steering Committee Meeting. The 

purpose of the meeting is to solicit 

public input prior to the next Steering 

Committee and Expert Working Group 

meetings in Fukuoka, Japan, scheduled 

on June 2 through 7, 2012, at which 

discussion of the topics underway and 

the future of ICH will continue. 

DATES: Date and Time: The public 

meeting will be held on May 14, 2012, 

from 2 p.m. to 4 p.m. 

Location: The public meeting will be 

held at the FDA White Oak Campus, 

10903 New Hampshire Ave., Bldg. 31, 

Conference Center, the Great Room (rm. 

1503), Silver Spring, MD 20993. 

Information regarding visitor parking 

and transportation may be accessed at: 

http://www.fda.gov/AboutFDA/

WorkingatFDA/BuildingsandFacilities/

WhiteOakCampusInformation/

ucm241740.htm; under the heading 

‘‘Public Meetings at the White Oak 

Campus.’’ Please note that visitors to the 

White Oak Campus must enter through 

Building 1. 

Contact Person: All participants must 

register with Kimberly Franklin, Office 

of the Commissioner, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Silver Spring, MD 20993–0002, 

FAX: 301–595–7937, email: Kimberly.

Franklin@fda.hhs.gov. 

Registration and Requests for Oral 

Presentations: Send registration 

information (including name, title, firm 

name, address, telephone, and fax 

number), written material, and requests 

to make oral presentations to the contact 

person (see Contact Person) by May 9, 

2012. 

Interested persons may present data, 

information, or views orally or in 

writing, on issues pending at the public 

meeting. Public oral presentations will 

be scheduled between approximately 

3:30 p.m. and 4 p.m. Time allotted for 

oral presentations may be limited to 10 

minutes. Those desiring to make oral 

presentations should notify the contact 

person (see Contact Person) by May 9, 

2012, and submit a brief statement of 

the general nature of the evidence or 

arguments they wish to present, the 

names and addresses, telephone 

number, fax, and email of proposed 

participants, and an indication of the 

approximate time requested to make 

their presentation. 

If you need special accommodations 

due to a disability, please contact 

Kimberly Franklin (see Contact Person) 

at least 7 days in advance. 

Transcripts: Please be advised that as 

soon as a transcript is available, it will 

be accessible at http://www.regulations.

gov. It may be viewed at the Division of 

Dockets Management (HFA–305), Food 

and Drug Administration, 5630 Fishers 

Lane, rm. 1061, Rockville, MD. A 

transcript will also be available in either 

hardcopy or on CD–ROM, after 

submission of a Freedom of Information 

request. Written requests are to be sent 

to Division of Freedom of Information 

(ELEM–1029), Food and Drug 

Administration, 12420 Parklawn Dr., 

Element Bldg., Rockville, MD 20857. 

SUPPLEMENTARY INFORMATION: The ICH 

was established in 1990 as a joint 

regulatory/industry project to improve, 

through harmonization, the efficiency of 

the process for developing and 

registering new medicinal products in 


pmangrum on DSK3VPTVN1PROD with NOTICES